Shanghai Kehua Bio-Engineering Co.,Ltd (SHE:002022)
China flag China · Delayed Price · Currency is CNY
6.13
-0.01 (-0.16%)
Feb 13, 2026, 3:04 PM CST

SHE:002022 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Operating Revenue
1,5871,7462,4176,9164,8444,151
Other Revenue
13.2113.2111.4754.2910.624.54
1,6001,7592,4286,9704,8544,155
Revenue Growth (YoY)
-14.61%-27.55%-65.16%43.58%16.82%72.10%
Cost of Revenue
1,2021,2471,4833,4052,2081,775
Gross Profit
397.87511.95944.723,5642,6472,381
Selling, General & Admin
776.18769.85877.111,258809.79835.53
Research & Development
165.29198.67241.36250.49148.47146.93
Other Operating Expenses
26.1210.2-41.22-118.056.089.69
Operating Expenses
1,1671,1671,0861,448978.511,003
Operating Income
-769.54-654.72-140.952,1171,6681,378
Interest Expense
-26.11-42.23-43.74-40.06-40.15-34.95
Interest & Investment Income
12.9633.4353.9248.2626.7912.67
Currency Exchange Gain (Loss)
-0.58-0.583.478.75-28.61-8.93
Other Non Operating Income (Expenses)
1.05-6.21-12.62-18.39-2.16-5.1
EBT Excluding Unusual Items
-782.21-670.3-1402,1851,6241,342
Impairment of Goodwill
-25.51-25.51-41.82-109.6-9.79-
Gain (Loss) on Sale of Investments
-2.11-1.171.47--1.96-
Gain (Loss) on Sale of Assets
4.654.215.024.532.064.68
Asset Writedown
-102.5-67.74-40.78-36.38-5.82-10.96
Legal Settlements
------0.62
Other Unusual Items
31.3225.5430.2420.7428.921.28
Pretax Income
-876.23-734.85-185.612,0651,6371,356
Income Tax Expense
1.31-4.2-8.62332.96283.58213.84
Earnings From Continuing Operations
-877.54-730.65-176.991,7321,3541,142
Minority Interest in Earnings
126.5490.05-57.03-760.66-503.41-466.85
Net Income
-750.99-640.6-234.01971.56850.41675.36
Net Income to Common
-750.99-640.6-234.01971.56850.41675.36
Net Income Growth
---14.25%25.92%233.55%
Shares Outstanding (Basic)
511505514514514506
Shares Outstanding (Diluted)
511505514533532513
Shares Change (YoY)
0.55%-1.83%-3.55%0.27%3.75%-0.10%
EPS (Basic)
-1.47-1.27-0.461.891.651.33
EPS (Diluted)
-1.47-1.27-0.461.821.601.32
EPS Growth
---13.94%21.37%233.88%
Free Cash Flow
-174.77-304.94-805.821,726863.191,109
Free Cash Flow Per Share
-0.34-0.60-1.573.241.622.16
Dividend Per Share
---0.6000.0650.200
Dividend Growth
---823.08%-67.50%207.69%
Gross Margin
24.86%29.10%38.91%51.14%54.52%57.29%
Operating Margin
-48.09%-37.22%-5.80%30.37%34.36%33.16%
Profit Margin
-46.93%-36.41%-9.64%13.94%17.52%16.25%
Free Cash Flow Margin
-10.92%-17.33%-33.19%24.76%17.78%26.70%
EBITDA
-524.56-433.5748.412,2831,7961,512
EBITDA Margin
-32.78%-24.65%1.99%32.75%37.01%36.38%
D&A For EBITDA
244.98221.14189.36165.77128.27133.8
EBIT
-769.54-654.72-140.952,1171,6681,378
EBIT Margin
-48.09%-37.22%-5.80%30.37%34.36%33.16%
Effective Tax Rate
---16.12%17.32%15.77%
Revenue as Reported
1,6001,7592,4286,9704,8544,155
Advertising Expenses
-16.4730.1259.5947.0117.66
Source: S&P Global Market Intelligence. Standard template. Financial Sources.